QSA's Week in BioPharma (#1, 2024)

Canada passes Pharmacare Act; G7 Health Ministers discuss future health emergencies; Halifax startups receive funding; Indigenous health research funding renewed.

QSA's Week in BioPharma (#1, 2024)

Start Date: 2024-10-05
End Date: 2024-10-11

Top Headlines

Main Stories

Canada Passes Pharmacare Legislation

On October 10, 2024, the Government of Canada announced the passage of the Pharmacare Act, marking the first phase of a national universal pharmacare program. This legislation provides universal access to contraception and diabetes medications, aiming to alleviate financial burdens for Canadians. The Act also requires the development of a national formulary and a bulk purchasing strategy to reduce drug prices. An expert committee will be established within thirty days to recommend the operation and financing of this program, indicating significant implications for pharmaceutical companies regarding drug pricing and market access.

Sources: ['Announcements: www.canada.ca']